Source: Virtual Congress 2021 – Asthma burden and management I



Rating:

Share or cite this content

Citations should be made in the following way:
J. Busby (Belfast, United Kingdom), J. Matthews (California, United States of America), R. Chaudhuri (Glasgow, United Kingdom), I. Pavord (Oxford, United Kingdom), T. Hardman (Kingston-Upon-Thames, United Kingdom), J. Arron (California, United States of America), P. Bradding (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom), D. Choy (California, United States of America), D. Cowan (Glasgow, United Kingdom), R. Djukanovic (Southampton, United Kingdom), C. Hanratty (Belfast, United Kingdom), T. Harrison (Nottingham, United Kingdom), C. Holweg (California, United States of America), P. Howarth (Southampton, United Kingdom), S. Fowler (Manchester, United Kingdom), J. Lordan (Newcastle upon Tyne, United Kingdom), A. Mansur (Birmingham, United Kingdom), A. Menzies-Gow (London, United Kingdom), R. Niven (Manchester, United Kingdom), D. Robinson (London, United Kingdom), S. Walker (London, United Kingdom), A. Woodcock (Manchester, United Kingdom), L. Heaney (Belfast, United Kingdom). Factors affecting patients’ decision to adjust treatment; secondary analysis of a randomised trial of treatment optimisation in patients with severe asthma. 638

Member's Comments

No comment yet.

Related content which might interest you: Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial Source: Eur Respir J, 54 (5) 1802134; 10.1183/13993003.02134-2018 Year: 2019 Effect of excluding ICU-admission on clinical outcomes in a randomized control trial studying the effect of corticosteroids in patients hospitalized with CAP Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Effects of case management on hospitalisation and exacerbation rate in severe, complex COPD: A randomized controlled trial Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011 Effectiveness of an individualized action plan on health status recovery in patients with COPD: A randomized controlled trial Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care Year: 2010 Less is more: the impact of maintenance treatment adherence in severe asthma clinical trials Source: Eur Respir J, 53 (5) 1900599; 10.1183/13993003.00599-2019 Year: 2019 A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma Source: Eur Respir J, 51 (1) 1701126; 10.1183/13993003.01126-2017 Year: 2018 Multidimensional assessment and targeted therapy of severe asthma: a randomised controlled trial (RCT) Source: International Congress 2017 – Many faces of asthma assessment Year: 2017 Benefits of interferon-αcon-1 (IFN-αcon-1) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy. Results of a 12-month prospective case-controlled study Source: Eur Respir J 2006; 28: Suppl. 50, 439s Year: 2006 Using placebo-controlled trials to define predictors of future exacerbations in severe asthma patients Source: Eur Respir J, 58 (6) 2101702; 10.1183/13993003.01702-2021 Year: 2021 Mandibular advancement therapy does not reduce inflammatory and metabolic biomarkers in patients with severe OSA: a randomized controlled trial Source: International Congress 2018 – Upper airways morphology and diagnostics, and the challenges associated with mandibular advancement Year: 2018 myAirCoach: mHealth assisted self-management in patients with uncontrolled asthma, a randomized control trial. Source: International Congress 2019 – M-health/e-health II Year: 2019 Evidence generation for the clinical impact of myCOPD in patients with mild, moderate and newly diagnosed COPD: a randomised controlled trial Source: ERJ Open Res, 6 (4) 00460-2020; 10.1183/23120541.00460-2020 Year: 2020 Utility of adherence checks in patients with severe asthma eligible for biologics: a single centre retrospective analysis Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Long-term efficacy of a home-based airway clearance programme to improve cough severity in patients with bronchiectasis:a randomised controlled trial> Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections Year: 2019 Cluster randomised controlled trial of the effect of introduction of an acute wheeze/asthma integrated care pathway on patient outcome Source: Eur Respir J 2006; 28: Suppl. 50, 481s Year: 2006 Patients’ adherence to chronic treatment in lung diseases: Preliminary data from a randomized controlled trial Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Safety and benefit of adjunctive systemic corticosteroid therapy in the management of severe, smear positive pulmonary tuberculosis (SSP-PTB); an interim analysis of a randomized controlled trial Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Do marker states improve measurement properties of utility instruments: a randomized multi-center trial in patients with chronic respiratory disease Source: Eur Respir J 2004; 24: Suppl. 48, 295s Year: 2004 A randomised clinical trial to assess the effect of active muscle stimulation on hospitalised patients with COPD exacerbations Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance Year: 2012 Dyspnoea and clinical outcome in critically ill patients receiving noninvasive support for COVID-19 respiratory failure: post hoc analysis of a randomised clinical trial Source: ERJ Open Res, 7 (4) 00418-2021; 10.1183/23120541.00418-2021 Year: 2021